Ulcers Formation After Hand-Sewn vs Stapled Gastrojejunal Anastomosis In MGB.
NCT ID: NCT06077955
Last Updated: 2024-04-02
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
RECRUITING
Clinical Phase
NA
Total Enrollment
300 participants
Study Classification
INTERVENTIONAL
Study Start Date
2023-11-01
Study Completion Date
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We assume that the frequency of gastrojejunostomy ulcers after MGB-OAGB is associated with the peculiarities of the side-to-side gastrojejunostomy (GJS) formation, which is currently the "gold standard" for this procedure. The geometry of such anastomosis leads to the formation of a narrow strip of the gastric wall between two stapler lines (between the suture from the 2nd cassette during the formation of the "small ventricle" and directly from the suture from the cassette during the GJS formation). Perhaps this section of the stomach wall is prone to ischemia, which can certainly increase the risk of ulcer formation. It is also possible that a zone with impaired blood supply may also form in the "blind pocket" above the anastomosis.
When forming a Hand-Sewn GJS of the end-to-side type, ischemia zones do not occur. The anastomosis has a more physiological geometry, there is no conflict between the lines of stapled sutures.
Thus, we put forward the assumption that a serious risk factor for the development of a GJS ulcer was eliminated when switching to a completely manual technique for the GJS formation when performing MGB-OAGB.
The study is aimed at the compare the incidence of GJS ulcers during MGB-OAGB, depending on the techniques of anastomosis formation.
When forming a Hand-Sewn GJS of the end-to-side type, ischemia zones do not occur. The anastomosis has a more physiological geometry, there is no conflict between the lines of stapled sutures.
Thus, we put forward the assumption that a serious risk factor for the development of a GJS ulcer was eliminated when switching to a completely manual technique for the GJS formation when performing MGB-OAGB.
The study is aimed at the compare the incidence of GJS ulcers during MGB-OAGB, depending on the techniques of anastomosis formation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Overstich Technique for the Management of Weight Regain After Gastric Bypass.
NCT02048033
the Management of Weight Regain After Gastric Bypass by Endoscopic Suturing
TERMINATED
NA
Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Quality of Life in Patients Undergoing Total Gastrectomy
NCT01697943
Gastric Tumor
UNKNOWN
PHASE3
Regain Rate According to gj Anastomosis Size in Gastric Bypass
NCT05655975
Obesity, Morbid
Anastomosis
Roux-en-y Anastomosis Site
UNKNOWN
NA
Hand-sewn and Linear-stapled Roux-en-Y Gastric Bypass: Outcomes
NCT03199352
Roux-en-y Anastomosis Site
WITHDRAWN
Stratafix Vs. Vicryl OAGB / MGB Suture Study
NCT04613635
Morbid Obesity
Anastomotic Leak
Anastomotic Stenosis
+1 more
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Today, MGB-OAGB, a mini-gastric bypass or one anastomosis gastric bypass, is one of the most widely used bariatric procedures. This surgery was first performed by Professor R. Rutledge in 1997, having published the first data in 2001 on a sample of 1274 patients \[1\]. In 2014, the first consensus conference was held, at which recommendations for application and generalization of experience were adopted \[2\]. By 2018, the share of MGB-OAGB surgeries in the world was already 7.7% \[3\]. In the Russian Federation, this index for 2021 was 12%, which indicates a significant prevalence of mini-gastric bypass surgery in the Russian Federation \[4\]. This is facilitated by the simplicity, safety and high efficiency of this procedure in relation to obesity and metabolic disorders. Comparative studies and subsequent meta-analyses show a number of advantages over the classic Roux-en-Y gastric bypass \[5, 6\]. Reduction in the duration of the surgery and the reduction in the number of surgical complications are attractive for surgeons.
However, with the increase in the number of surgeries and the accumulation of experience, a number of problems associated with this surgery become apparent. Malabsorption risks are minimized by measuring the length of the common loop and cutting off a strictly defined percentage of the small intestine from digestion. Research on bile reflux effects is currently ongoing, but in order to reduce it, the surgical technique has been modified by lengthening the gastric tube \[2\]. One of the most serious problems is the appearance of gastrojejunostomy (GJS) ulcers. As a rule, they are difficult to treat and can cause bleeding. Their number seriously varies in different publications from 2% to 13% \[7, 8\]. These figures, despite the attractiveness of the new surgery, make many surgeons refrain from performing MGB-OAGB in their routine practice. The causes of ulcers are not fully understood and require further study, and it is also possible to change the technique of anastomosis.
Working Hypothesis We assume that the frequency of gastrojejunostomy ulcers after MGB-OAGB is associated with the peculiarities of the side-to-side GJS formation, which is currently the "gold standard" for this procedure. The geometry of such anastomosis leads to the formation of a narrow strip of the gastric wall between two stapler lines (between the suture from the 2nd cassette during the formation of the "small ventricle" and directly from the suture from the cassette during the GJS formation). Perhaps this section of the stomach wall is prone to ischemia, which can certainly increase the risk of ulcer formation. It is also possible that a zone with impaired blood supply may also form in the "blind pocket" above the anastomosis.
When forming a Hand-sewn GJS of the end-to-side type, ischemia zones do not occur. The anastomosis has a more physiological geometry, there is no conflict between the lines of stapled sutures.
Thus, we put forward the assumption that a serious risk factor for the development of a GJS ulcer was eliminated when switching to a completely Hand-sewn technique for the GJS formation when performing MGB-OAGB.
Purpose of the Study To compare the incidence of GJS ulcers during MGB-OAGB, depending on the techniques of anastomosis formation.
Materials and Research Methods In order to assess the target parameter and the endpoint of the study, all patients who underwent surgical treatment will undergo a video endoscopy of the upper gastrointestinal tract 6 months after surgical treatment.
As research tools, it is planned to use instrumental, laboratory and surgery equipment, as well as all other necessary material and technical equipment of the above medical institutions.
Treatment Protocol All eligible and randomized patients will undergo laparoscopic MGB-OAGB no later than 1 month after randomization and enrollment. As part of a standardized preoperative assessment, a set of examinations will be performed, see Appendix 2.
Standardized surgery protocol:
* One-time antibacterial prophylaxis is performed, activities are carried out for the induction of anesthesia, tracheal intubation and the implementation of inhalation anesthesia with mechanical ventilation in accordance with the local standards of the participating centers.
* Patient is placed in the supine position with the head of the bed elevated at 30° (Fowler's position).
* A carboxyperitoneum is created with a pressure of 12-16 mm Hg.
* Five trocars are installed in the upper mesogastrium according to the accepted technique for performing surgical interventions on the upper floor of the abdominal cavity in each specific clinical center.
* By one of the types of surgical energy (ultrasound, bipolar, monopolar) along the lesser curvature of the stomach, the lesser omentum is dissected and the omentum is entered from the omental bag at or distal to the crow's foot, the minimally necessary retrogastric adhesiolysis is performed.
* The gastroesophageal junction and the angle of His are mobilized. Then the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). Blue, green, gold, purple, and black cassettes (cassettes or cartridges in blue, green, black, or purple) can be used.
* Staple line hemostasis by applying clips.
* The greater omentum may be transversely incised depending on individual anatomy.
* Visualization of the ligament of Treitz.
* Measurement of the length of the small intestine at a distance of at least 5 m.
* A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a linear stapler in group A and using a fully Hand-sewn suture in group B.
* Gastrotomy at the end section of the stapler line of the distal "small ventricle" and enterotomy at 150-200 cm from the ligament of Treitz are performed in group A. GJS is formed using a blue or purple cartridge (the height of the braces is 3.5 mm). The width of the formed anastomosis is calibrated according to the branch of the apparatus of 35-40 cm. The technological hole is closed with absorbable monofilament suture material with a biodegradation time of not more than 180 days on a pricking needle.
* Extended gastrotomy by cutting off the end stapler line (1st cassette, when forming the "small ventricle") is performed in group B. Enterotomy with a length of 35-40 mm is performed at a distance of 150-200 cm from the ligament of Treitz. GJS is formed by a manual single-row continuous suture using any absorbable monofilament suture material with a biodegradation period of not more than 180 days on a pricking needle.
* Performing an anastomosis leak test with a solution of methylene blue or bubble leak test.
* Testing for hemostasis.
* Desufflation of gas and suturing of trocar wounds are carried out.
After the surgical intervention, if necessary, the patient can be in the intensive care unit and monitoring until the stabilization of the condition, then transferred to the specialized surgical department.
Recommendations for nutrition after surgery: oral intake of light glucose-containing liquids begins on the first postoperative day (6-12 hours after surgery). On the second day after the surgery, the intake of concentrated glucose-containing and complex nutritional drinks begins.
After discharge from the hospital, the patient must adhere to the protocol diet (Appendix 3). All patients will be required to take preventive therapy with an established PPIs 40 mg daily for 6 months after surgery.
Intermediate Control From the moment of discharge from the hospital until the moment of assessment of the target parameter, remote monitoring will be carried out to control the patient's compliance (regularity of PPI intake, adherence to recommendations on the postoperative diet) and complaints, possibly associated with the early onset of erosive and ulcerative lesions of the upper gastrointestinal tract. Telephone control will be carried out in periods of 1, 2, 3 and 5 months after surgical treatment.
In the event of a premature referral of the patient or detection of complaints during the intermediate control, indicating the possible development of erosive and ulcerative lesions of the upper gastrointestinal tract, the patient will undergo a premature flexible endoscopy of the upper gastrointestinal tract. If a GJS ulcer is detected, the endpoint will prematurely be assessed as positive.
Expected Results It is expected to reveal a statistically significant reduction in the incidence of GJS ulceration when performing MGB-OAGB using a Hand-sewn anastomosis technique compared with a stapled technique.
However, with the increase in the number of surgeries and the accumulation of experience, a number of problems associated with this surgery become apparent. Malabsorption risks are minimized by measuring the length of the common loop and cutting off a strictly defined percentage of the small intestine from digestion. Research on bile reflux effects is currently ongoing, but in order to reduce it, the surgical technique has been modified by lengthening the gastric tube \[2\]. One of the most serious problems is the appearance of gastrojejunostomy (GJS) ulcers. As a rule, they are difficult to treat and can cause bleeding. Their number seriously varies in different publications from 2% to 13% \[7, 8\]. These figures, despite the attractiveness of the new surgery, make many surgeons refrain from performing MGB-OAGB in their routine practice. The causes of ulcers are not fully understood and require further study, and it is also possible to change the technique of anastomosis.
Working Hypothesis We assume that the frequency of gastrojejunostomy ulcers after MGB-OAGB is associated with the peculiarities of the side-to-side GJS formation, which is currently the "gold standard" for this procedure. The geometry of such anastomosis leads to the formation of a narrow strip of the gastric wall between two stapler lines (between the suture from the 2nd cassette during the formation of the "small ventricle" and directly from the suture from the cassette during the GJS formation). Perhaps this section of the stomach wall is prone to ischemia, which can certainly increase the risk of ulcer formation. It is also possible that a zone with impaired blood supply may also form in the "blind pocket" above the anastomosis.
When forming a Hand-sewn GJS of the end-to-side type, ischemia zones do not occur. The anastomosis has a more physiological geometry, there is no conflict between the lines of stapled sutures.
Thus, we put forward the assumption that a serious risk factor for the development of a GJS ulcer was eliminated when switching to a completely Hand-sewn technique for the GJS formation when performing MGB-OAGB.
Purpose of the Study To compare the incidence of GJS ulcers during MGB-OAGB, depending on the techniques of anastomosis formation.
Materials and Research Methods In order to assess the target parameter and the endpoint of the study, all patients who underwent surgical treatment will undergo a video endoscopy of the upper gastrointestinal tract 6 months after surgical treatment.
As research tools, it is planned to use instrumental, laboratory and surgery equipment, as well as all other necessary material and technical equipment of the above medical institutions.
Treatment Protocol All eligible and randomized patients will undergo laparoscopic MGB-OAGB no later than 1 month after randomization and enrollment. As part of a standardized preoperative assessment, a set of examinations will be performed, see Appendix 2.
Standardized surgery protocol:
* One-time antibacterial prophylaxis is performed, activities are carried out for the induction of anesthesia, tracheal intubation and the implementation of inhalation anesthesia with mechanical ventilation in accordance with the local standards of the participating centers.
* Patient is placed in the supine position with the head of the bed elevated at 30° (Fowler's position).
* A carboxyperitoneum is created with a pressure of 12-16 mm Hg.
* Five trocars are installed in the upper mesogastrium according to the accepted technique for performing surgical interventions on the upper floor of the abdominal cavity in each specific clinical center.
* By one of the types of surgical energy (ultrasound, bipolar, monopolar) along the lesser curvature of the stomach, the lesser omentum is dissected and the omentum is entered from the omental bag at or distal to the crow's foot, the minimally necessary retrogastric adhesiolysis is performed.
* The gastroesophageal junction and the angle of His are mobilized. Then the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). Blue, green, gold, purple, and black cassettes (cassettes or cartridges in blue, green, black, or purple) can be used.
* Staple line hemostasis by applying clips.
* The greater omentum may be transversely incised depending on individual anatomy.
* Visualization of the ligament of Treitz.
* Measurement of the length of the small intestine at a distance of at least 5 m.
* A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a linear stapler in group A and using a fully Hand-sewn suture in group B.
* Gastrotomy at the end section of the stapler line of the distal "small ventricle" and enterotomy at 150-200 cm from the ligament of Treitz are performed in group A. GJS is formed using a blue or purple cartridge (the height of the braces is 3.5 mm). The width of the formed anastomosis is calibrated according to the branch of the apparatus of 35-40 cm. The technological hole is closed with absorbable monofilament suture material with a biodegradation time of not more than 180 days on a pricking needle.
* Extended gastrotomy by cutting off the end stapler line (1st cassette, when forming the "small ventricle") is performed in group B. Enterotomy with a length of 35-40 mm is performed at a distance of 150-200 cm from the ligament of Treitz. GJS is formed by a manual single-row continuous suture using any absorbable monofilament suture material with a biodegradation period of not more than 180 days on a pricking needle.
* Performing an anastomosis leak test with a solution of methylene blue or bubble leak test.
* Testing for hemostasis.
* Desufflation of gas and suturing of trocar wounds are carried out.
After the surgical intervention, if necessary, the patient can be in the intensive care unit and monitoring until the stabilization of the condition, then transferred to the specialized surgical department.
Recommendations for nutrition after surgery: oral intake of light glucose-containing liquids begins on the first postoperative day (6-12 hours after surgery). On the second day after the surgery, the intake of concentrated glucose-containing and complex nutritional drinks begins.
After discharge from the hospital, the patient must adhere to the protocol diet (Appendix 3). All patients will be required to take preventive therapy with an established PPIs 40 mg daily for 6 months after surgery.
Intermediate Control From the moment of discharge from the hospital until the moment of assessment of the target parameter, remote monitoring will be carried out to control the patient's compliance (regularity of PPI intake, adherence to recommendations on the postoperative diet) and complaints, possibly associated with the early onset of erosive and ulcerative lesions of the upper gastrointestinal tract. Telephone control will be carried out in periods of 1, 2, 3 and 5 months after surgical treatment.
In the event of a premature referral of the patient or detection of complaints during the intermediate control, indicating the possible development of erosive and ulcerative lesions of the upper gastrointestinal tract, the patient will undergo a premature flexible endoscopy of the upper gastrointestinal tract. If a GJS ulcer is detected, the endpoint will prematurely be assessed as positive.
Expected Results It is expected to reveal a statistically significant reduction in the incidence of GJS ulceration when performing MGB-OAGB using a Hand-sewn anastomosis technique compared with a stapled technique.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Ulcer Peptic
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Two groups: group A, a variant of the surgery with the stapled formation of a GJS, and group B, a variant with a hand-sewn formation of a GJS.
Primary Study Purpose
TREATMENT
Blinding Strategy
SINGLE
Participants
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A (control) - with stapled anastomosis
A variant of the surgery with the stapled formation of a gastrojejunostomy.
Group Type
ACTIVE_COMPARATOR
Mini-gastric bypass with stapled anastomosis
Intervention Type
PROCEDURE
the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). • A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a linear stapler.
Group B (study) - with hand-sewn anastomosis
A variant with a hand-sewn formation of a gastrojejunostomy.
Group Type
EXPERIMENTAL
Mini-gastric bypass with hand-sewn anastomosis
Intervention Type
PROCEDURE
the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). • A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a fully manual suture.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mini-gastric bypass with stapled anastomosis
the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). • A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a linear stapler.
Intervention Type
PROCEDURE
Mini-gastric bypass with hand-sewn anastomosis
the stomach is transected using linear endoscopic staplers in such a way as to create an isolated narrow gastric tube ("small ventricle") at least 17-18 cm long and 15-20 mm wide (diameter of gastric tube used 36-39 Fr). • A gastroenterostomy is performed at a distance of 150-200 cm from the ligament of Treitz using a fully manual suture.
Intervention Type
PROCEDURE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women aged 18 to 65;
* Body mass index over 40 kg/m2 or 35 kg/m2 in the presence of concomitant metabolic disorders (type 2 diabetes mellitus, hypertension, coronary artery disease, atherosclerosis and dyslipidemia);
* Preliminary consultation with an endocrinologist;
* Voluntary informed consent for surgical treatment;
* Voluntary informed consent to participate in a clinical trial;
* A negative test for Helicobacter pylori or a full course of eradication therapy.
* smoking;
* gastric ulcer disease in history;
* earlier abdominal surgery by laparotomy
* abdominal wall hernias;
* contraindications to planned operative treatment of bariatric profile based on the results of the pre-surgery evaluation of somatic status (see section "Patient's Treatment Protocol");
* for women - pregnancy planning in the next 12 months;
* mental health record;
* patients with oncological diseases;
* Body mass index over 40 kg/m2 or 35 kg/m2 in the presence of concomitant metabolic disorders (type 2 diabetes mellitus, hypertension, coronary artery disease, atherosclerosis and dyslipidemia);
* Preliminary consultation with an endocrinologist;
* Voluntary informed consent for surgical treatment;
* Voluntary informed consent to participate in a clinical trial;
* A negative test for Helicobacter pylori or a full course of eradication therapy.
* smoking;
* gastric ulcer disease in history;
* earlier abdominal surgery by laparotomy
* abdominal wall hernias;
* contraindications to planned operative treatment of bariatric profile based on the results of the pre-surgery evaluation of somatic status (see section "Patient's Treatment Protocol");
* for women - pregnancy planning in the next 12 months;
* mental health record;
* patients with oncological diseases;
Exclusion Criteria
* surgical complications in the early post-surgery period related to the disruption of vital functions of organs and systems (respiratory, neurological and cardiological disorders requiring a stay in then the intensive-care unit, long-term position compression syndrome with renal impairment, venous thromboembolism);
* surgical complications in the early post-surgery period requiring repeated surgery or minimally invasive surgery (intraabdominal / intraluminal hemorrhage, failure of manual/ hardware suture on gastrointestinal organs etc.);
* positive intraoperative test for leak-proof anastomosis (injection of methylene blue solution or "bubble-test"), requiring surgical procedures for color leakage zone removal (see section "Patient's Treatment Protocol");
* poor adherence to the recommendations for gastroprotective therapy and recommendations on diet after surgery by the patient (see section "Interim control");
* patient's refusal to participate in the clinical study at any stage.
* surgical complications in the early post-surgery period requiring repeated surgery or minimally invasive surgery (intraabdominal / intraluminal hemorrhage, failure of manual/ hardware suture on gastrointestinal organs etc.);
* positive intraoperative test for leak-proof anastomosis (injection of methylene blue solution or "bubble-test"), requiring surgical procedures for color leakage zone removal (see section "Patient's Treatment Protocol");
* poor adherence to the recommendations for gastroprotective therapy and recommendations on diet after surgery by the patient (see section "Interim control");
* patient's refusal to participate in the clinical study at any stage.
Minimum Eligible Age
18 Years
Maximum Eligible Age
65 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aleksandr E. Neimark
Leading researcher
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aleksandr Neimark, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Almazov National Medical Research Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Almazov National Medical Research Centre
Saint Petersburg, , Russia
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
Russia
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Alexandr Neimark
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001 Jun;11(3):276-80. doi: 10.1381/096089201321336584.
Reference Type
BACKGROUND
Ramos AC, Chevallier JM, Mahawar K, Brown W, Kow L, White KP, Shikora S; IFSO Consensus Conference Contributors. IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) Consensus Conference Statement on One-Anastomosis Gastric Bypass (OAGB-MGB): Results of a Modified Delphi Study. Obes Surg. 2020 May;30(5):1625-1634. doi: 10.1007/s11695-020-04519-y.
Reference Type
BACKGROUND
Welbourn R, Hollyman M, Kinsman R, Dixon J, Liem R, Ottosson J, Ramos A, Vage V, Al-Sabah S, Brown W, Cohen R, Walton P, Himpens J. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019 Mar;29(3):782-795. doi: 10.1007/s11695-018-3593-1. Epub 2018 Nov 12.
Reference Type
BACKGROUND
National Bariatric Registry. URL: https://bareoreg.ru (Accessed: 01.08.2023).
Reference Type
BACKGROUND
Ruiz-Tovar J, Carbajo MA, Jimenez JM, Castro MJ, Gonzalez G, Ortiz-de-Solorzano J, Zubiaga L. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities. Surg Endosc. 2019 Feb;33(2):401-410. doi: 10.1007/s00464-018-6307-9. Epub 2018 Jun 25.
Reference Type
BACKGROUND
Wang FG, Yan WM, Yan M, Song MM. Outcomes of Mini vs Roux-en-Y gastric bypass: A meta-analysis and systematic review. Int J Surg. 2018 Aug;56:7-14. doi: 10.1016/j.ijsu.2018.05.009. Epub 2018 May 16.
Reference Type
BACKGROUND
Mahawar KK, Reed AN, Graham YNH. Marginal ulcers after one anastomosis (mini) gastric bypass: a survey of surgeons. Clin Obes. 2017 Jun;7(3):151-156. doi: 10.1111/cob.12186. Epub 2017 Mar 20.
Reference Type
BACKGROUND
Baksi A, Kamtam DNH, Aggarwal S, Ahuja V, Kashyap L, Shende DR. Should Surveillance Endoscopy Be Routine After One Anastomosis Gastric Bypass to Detect Marginal Ulcers: Initial Outcomes in a Tertiary Referral Centre. Obes Surg. 2020 Dec;30(12):4974-4980. doi: 10.1007/s11695-020-04864-y. Epub 2020 Jul 27.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0210-22-MGB-OAGB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy
NCT06383793
RECRUITING
Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes.
NCT06176443
COMPLETED
NA
Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)
NCT00254072
COMPLETED
NA
Reconstruction With a Lawrence-Hunt Jejunal Pouch After Total Gastrectomy
NCT06967571
ACTIVE_NOT_RECRUITING
NA
A Clinical Study of Laparoscopic Proximal Gastrectomy Based on PTST(Parachute-tunnel- Style Technique) Esophagogastric Anastomose.
NCT06217991
ENROLLING_BY_INVITATION
NA
Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer
NCT02085031
UNKNOWN
PHASE2
Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal Gastrectomy
NCT02763878
UNKNOWN
PHASE3
MGB/OAGB and LSG Effects on Lower Esophageal Sphincter (LES) Function
NCT02987673
UNKNOWN
NA
Novel Balloon-Assisted vs Direct Technique in EUS-Guided Gastroenterostomy
NCT07161856
NOT_YET_RECRUITING
NA
Single Anastomosis Sleeve Jejunal Bypass Versus One Anastomosis Gastric Bypass in Management of Morbid Obese Patients: A Comparative Study
NCT06857097
NOT_YET_RECRUITING
NA
Perforated Marginal Ulcer After Gastric Bypass
NCT01041196
COMPLETED
The FundoRingOAGB Versus Non-wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass
NCT04834635
COMPLETED
NA
A Banded One Anastomosis Gastric Bypass With Use Shape-memory Ring Versus Non-banded One Anastomosis Gastric Bypass
NCT04762849
WITHDRAWN
NA
Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index
NCT04845438
UNKNOWN
NA
Stapled vs Hand Sewn Anastomosis in Roux en Y Gastric Bypass for Morbid Obesity: Randomized Clinical Trial
NCT02077517
UNKNOWN
PHASE3
OAGB-MGB Conversions for Post-operative Complications
NCT04641715
COMPLETED
Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal Gastrectomy
NCT06062225
NOT_YET_RECRUITING
NA
Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy
NCT02110628
UNKNOWN
PHASE3
Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy
NCT02837874
UNKNOWN
NA
Extended Pouch Gastric Bypass vs One-anastomosis Gastric Bypass in Patients With BMI≥45
NCT06204939
NOT_YET_RECRUITING
NA
Oversewing Staple Line of The Gastric Remnant
NCT04884230
COMPLETED
TROCAR SITE HERNIA AFTER LSG
NCT04849403
COMPLETED
NA
MGB/OAGB Versus RYGB After Failed Sleeve
NCT03526783
COMPLETED
NA
Internal Hernias After Laparoscopic Gastric Bypass
NCT01040364
COMPLETED
Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer
NCT00746161
COMPLETED
PHASE3